Investment Pitches

Pitch Summary:
Vistra Corp. is an integrated retail and power generation company with operations across the U.S., primarily serving Texas and the Midwest. We believe Vistra is well-positioned to capitalize on the structural tightening of power markets, as electricity demand accelerates, and baseload generation capacity continues to retire. This trend has been amplified by the rapid growth of AI, which is driving unprecedented demand for data centers and the power required to run them. These factors create a favorable pricing environment for Vistra's generation fleet, especially its nuclear and gas assets. The company has locked in much of this value via hedging, providing clear visibility into future cash flows. Vistra has also successfully grown its retail business and completed a strategic acquisition of Energy Harbor, which added a portfolio of nuclear, retail, and renewable assets.

BSD Analysis:
The manager expresses strong conviction in Vistra's positioning within the structural tightening of U.S. power markets, driven by accelerating electricity demand and retiring baseload capacity. The investment thesis is anchored on the AI-driven data center boom creating unprecedented power demand, which benefits VST's diversified generation fleet, particularly nuclear and gas assets. The fund highlights Vistra's strategic hedging program that has locked in favorable pricing, providing clear cash flow visibility in a strengthening power market environment. The company's successful retail business growth and strategic acquisition of Energy Harbor demonstrate management's ability to capitalize on market opportunities while expanding its nuclear, retail, and renewable asset portfolio. The manager views Vistra as well-positioned to benefit from the structural supply-demand imbalance in power markets, with AI and data center growth serving as a powerful long-term demand catalyst. This suggests confidence in VST's ability to generate superior returns in a favorable regulatory and market environment.

Pitch Summary:
Amazon.com, Inc. is a global leader in e-commerce and cloud computing, uniquely positioned to benefit from the secular growth in digital commerce and enterprise cloud adoption. Our investment in Amazon reflects its ability to compound growth through its dominant retail platform, AWS cloud infrastructure, and emerging high-margin businesses like advertising and logistics services. The company delivered strong third-quarter results, exceeding expectations for both revenue and operating income despite mixed macro signals. Amazon's investments in operational efficiency, particularly in inventory management and automation, have driven meaningful margin expansion. AWS maintained its leadership position in cloud infrastructure, securing significant new customer wins and showing healthy demand for new workloads. Looking forward, we see multiple drivers of value creation through retail margin expansion, continued cloud growth, and the scaling of high-margin businesses.

BSD Analysis:
The manager maintains a bullish stance on Amazon, emphasizing the company's unique positioning to benefit from secular growth in digital commerce and enterprise cloud adoption. The investment thesis highlights AMZN's ability to compound growth across multiple high-quality business segments: dominant retail platform, AWS cloud infrastructure, and emerging high-margin services like advertising and logistics. Q3 results demonstrated operational excellence, with both revenue and operating income exceeding expectations despite mixed macro conditions. The fund particularly values Amazon's investments in operational efficiency, noting meaningful margin expansion driven by inventory management and automation improvements. AWS continues to demonstrate market leadership with significant new customer wins and healthy demand for new workloads. The manager's forward-looking view identifies multiple value creation drivers: retail margin expansion, continued cloud growth, and scaling of high-margin businesses. This suggests confidence in Amazon's ability to drive sustainable profit growth across its diversified platform.

Pitch Summary:
Visa, Inc. is the world's largest retail electronic payments network. We hold Visa in the portfolio because of its formidable competitive moat, built on network effects spanning billions of cards and millions of merchants globally. The company continues to benefit from the secular shift toward electronic payments while expanding its portfolio to include high-growth adjacent offerings. While U.S. market penetration is mature, international markets—particularly in emerging economies, where cash usage remains prevalent—offer significant growth opportunities. Visa's operating model demonstrates strong leverage, with incremental revenue efficiently flowing to the bottom line. This quarter, Visa outperformed expectations across key metrics, with payment volumes and transaction growth proving resilient despite macro uncertainties. Looking ahead, we anticipate continued momentum into fiscal 2025, driven by the ongoing transition to digital payments, international expansion, and the scaling of newer business lines.

BSD Analysis:
The manager expresses strong conviction in Visa's dominant position in the global payments ecosystem, emphasizing the company's formidable competitive moat built on network effects. The investment thesis centers on V's exposure to the secular shift toward electronic payments, with particular upside from international markets where cash usage remains prevalent, especially in emerging economies. The fund highlights Visa's highly leveraged operating model, where incremental revenue flows efficiently to the bottom line, demonstrating exceptional scalability. Q3 results exceeded expectations across key metrics, with payment volumes and transaction growth showing resilience despite macro uncertainties. The manager's bullish outlook extends into fiscal 2025, driven by three key catalysts: continued digital payment adoption, international expansion opportunities, and scaling of newer high-growth business lines. The fund views Visa as a high-quality compounder benefiting from structural payment digitization trends with significant runway for growth.

Pitch Summary:
Coty, Inc. is a global beauty company with a growing portfolio of prestige and consumer brands. We hold Coty for its transformation potential through strategic investments in brand development and expansion within high-growth beauty markets. Performance this quarter was impacted by broader retail headwinds, as distributors in the U.S., Australia, and Asian retail channels maintained cautious inventory positions. Weak sales in China further pressured results. Despite these challenges, management implemented cost-saving measures to protect margins while maintaining strategic growth initiatives. We anticipate sales momentum to reaccelerate, supported by holiday season performance and continued expansion of the prestige portfolio.

BSD Analysis:
The manager maintains a bullish view on Coty despite near-term headwinds, emphasizing the company's transformation potential in high-growth beauty markets. The investment thesis centers on COTY's strategic brand development initiatives and expansion of its prestige portfolio, which the fund believes will drive long-term value creation. Q3 performance was challenged by broader retail headwinds, with distributors across U.S., Australia, and Asian markets maintaining cautious inventory levels, while weak China sales added pressure. However, management's implementation of cost-saving measures to protect margins while preserving growth investments demonstrates operational discipline. The manager expects sales momentum to recover, supported by holiday seasonality and continued prestige portfolio expansion. The fund's conviction appears based on COTY's positioning in the structural growth of the beauty industry, viewing current retail challenges as temporary cyclical headwinds rather than fundamental deterioration.

Pitch Summary:
Danaher Corp. is a global leader in life sciences and diagnostics, with a strong presence in bioprocessing, medical research, and clinical diagnostics. We hold Danaher for its competitive positioning in growing end-markets, particularly its underappreciated non-COVID bioprocessing franchise, and its consistent free cash flow generation. Third-quarter results were mixed, with organic revenue growth surpassing guidance but falling short of broader expectations. Strength in bioprocessing orders contrasted with softness in life sciences instruments and ongoing inventory destocking. The diagnostics business delivered solid growth, driven by strong respiratory testing performance. Despite near-term challenges, we remain confident in Danaher's market leadership and its ability to capture renewed demand as conditions normalize. We also expect the company's operational excellence and strategic M&A capabilities to drive further value creation as end markets recover.

BSD Analysis:
The manager maintains conviction in Danaher despite mixed Q3 performance, focusing on the company's leadership position in life sciences and diagnostics markets. The investment thesis emphasizes DHR's underappreciated non-COVID bioprocessing franchise and consistent free cash flow generation as key value drivers. While organic revenue growth exceeded guidance, it fell short of broader market expectations, with strength in bioprocessing orders offset by weakness in life sciences instruments and continued inventory destocking headwinds. The diagnostics segment showed resilience with solid growth driven by respiratory testing demand. The manager's bullish stance is anchored on Danaher's market leadership, operational excellence, and strategic M&A capabilities, expecting these strengths to drive value creation as end markets normalize. The fund views current challenges as temporary, maintaining confidence in DHR's ability to capitalize on renewed demand in its core growth markets.

Pitch Summary:
American Tower Corp. is a leading global owner and operator of wireless communications infrastructure, with a portfolio spanning the U.S. and key international markets. We hold American Tower for its exposure to the secular growth in wireless data consumption and its strategic positioning in underpenetrated emerging markets. The company benefits from long-term contracts with investment-grade wireless carriers, providing strong visibility into future cash flows. This quarter, performance was mixed. Revenue met expectations but fell short of consensus. Adjusted EBITDA declined slightly year-over-year, impacted by the divestiture of its India business and elevated bad debt expense. However, organic tenant billings growth remained healthy, with U.S. and international markets posting solid growth. While we maintain conviction in American Tower's ability to benefit from increasing data consumption and 5G network deployments, near-term currency headwinds and regional challenges warrant monitoring.

BSD Analysis:
The manager maintains a bullish stance on American Tower despite mixed quarterly results, emphasizing the company's strategic positioning in the secular growth of wireless data consumption. The investment thesis centers on AMT's exposure to 5G network deployments and underpenetrated emerging markets, supported by long-term contracts with investment-grade carriers that provide cash flow visibility. While Q3 results showed revenue meeting expectations but falling short of consensus, with EBITDA declining due to the India divestiture and bad debt expenses, the manager highlights healthy organic tenant billings growth across U.S. and international markets. The fund views AMT as well-positioned for the structural increase in data consumption, though acknowledges near-term headwinds from currency fluctuations and regional market challenges. The manager's conviction remains intact despite performance volatility, suggesting confidence in the long-term wireless infrastructure investment theme.

Pitch Summary:
Angi, Inc. operates an online marketplace connecting homeowners with local, pre-screened home service professionals. During the quarter, Angi's stock price declined following continued revenue challenges amid its strategic business refocusing. Despite strong underlying metrics, including service professional retention and net promoter scores, uncertainty surrounding new regulatory rules and the decision by its majority owner to spin off its holdings, weighed on the stock. We view these challenges as temporary and remain committed to a patient, long-term approach. Angi's efforts to improve lead quality and expand EBITDA margins are promising, and we believe downside risks are limited. We slightly trimmed our position during the quarter and will continue to monitor progress.

BSD Analysis:
The manager maintains a bullish long-term view on Angi despite near-term headwinds and revenue challenges. The investment thesis is supported by strong underlying operational metrics, including service professional retention and net promoter scores, which indicate a healthy marketplace ecosystem. The manager views current challenges as temporary, stemming from strategic business refocusing and external factors rather than fundamental business deterioration. Regulatory uncertainty and the majority owner's spin-off decision have created temporary overhang, presenting a potential opportunity for patient investors. Management's focus on improving lead quality and expanding EBITDA margins demonstrates operational discipline and margin improvement potential. The online marketplace model for home services represents a large addressable market with network effects and scalability advantages. The manager's slight position trimming appears to be risk management while maintaining conviction in the long-term opportunity. Limited downside risk assessment suggests attractive risk-reward dynamics at current levels.

Pitch Summary:
Stoneridge, Inc. develops electronic safety systems primarily for automotive and commercial vehicles. The company's stock price fell during the quarter on weak earnings as the auto supplier segment continued to struggle. While the challenges within the segment were well known to us, we were optimistic that newly released products could offset the broader weakness. However, delayed uptake of these key new products, poor execution, and a deteriorating balance sheet drove our decision to trim the position.

BSD Analysis:
The manager has adopted a bearish stance on Stoneridge due to poor execution and deteriorating fundamentals in the challenging auto supplier environment. Despite awareness of sector headwinds, the investment thesis was predicated on new product launches offsetting broader industry weakness. However, delayed uptake of key new products has undermined this thesis, indicating either market acceptance issues or competitive challenges. Poor execution by management has compounded the operational difficulties, suggesting leadership may be struggling to navigate the current environment effectively. The deteriorating balance sheet represents a significant concern, potentially limiting the company's financial flexibility during a challenging period. The auto supplier segment continues to face structural pressures, and Stoneridge appears unable to differentiate itself from industry trends. The combination of execution issues, product launch delays, and balance sheet deterioration creates a concerning fundamental picture. The manager's position trimming reflects reduced confidence in management's ability to execute a successful turnaround.

Pitch Summary:
TransMedics Group, Inc. specializes in medical technologies that facilitate efficient organ transplantation, notably through its Organ Care System (OCS). The company faced headwinds during the quarter after reporting a modest miss on top-line growth and narrowing its forward guidance. Our ongoing modeling and tracking of the overall industry detected slowing incremental market share gains, bringing TransMedics' growth in line with industry trends. In response, we significantly reduced our position during the quarter.

BSD Analysis:
The manager has turned bearish on TransMedics following disappointing operational performance and slowing market dynamics. The investment case has deteriorated due to a modest revenue miss and management's decision to narrow forward guidance, indicating reduced confidence in near-term prospects. The manager's proprietary industry analysis revealed slowing incremental market share gains, suggesting TransMedics' competitive advantages may be diminishing. The company's growth trajectory is now aligning with broader industry trends rather than outperforming, which undermines the premium valuation typically associated with market leaders. The significant position reduction reflects a loss of confidence in the company's ability to maintain its historical growth premium. While the Organ Care System represents innovative technology in organ transplantation, execution challenges and market saturation concerns have emerged. The narrowing guidance suggests management faces visibility challenges in a potentially maturing market opportunity.

Pitch Summary:
Byrna Technologies, Inc. is a leader in non-lethal self-defense solutions for consumers and law enforcement. Its products, primarily sold through its e-commerce platform and Amazon, do not require background checks or firearm licenses. The stock extended its string of solid performance driven by effective advertising strategies that boosted revenue growth. We took advantage of the pricing strength to significantly trim our position and manage portfolio risk.

BSD Analysis:
The manager presents a bullish case for Byrna Technologies based on its leadership position in the non-lethal self-defense market. The investment thesis centers on the company's unique positioning in providing self-defense solutions that bypass traditional firearm regulations, as products don't require background checks or licenses. This regulatory advantage creates a significant addressable market opportunity among consumers seeking personal protection alternatives. The company's direct-to-consumer strategy through e-commerce and Amazon provides scalable distribution channels with attractive margins. Effective advertising strategies have successfully driven revenue growth, demonstrating the company's marketing capabilities and brand building. The manager's significant position trimming reflects risk management given the stock's strong performance rather than fundamental concerns. The non-lethal self-defense market represents a growing niche with favorable regulatory dynamics. Byrna's established market leadership and proven execution provide competitive advantages in this specialized sector.

Pitch Summary:
Turning Point Brands, Inc., a producer of branded consumer products including alternative smoking accessories, performed well during the quarter due to solid core business execution. Management provided positive guidance and introduced new metrics highlighting growth in its tobacco-free nicotine pouches, a promising segment gaining market share. We reduced our position during the quarter as the price strengthened.

BSD Analysis:
The manager maintains a positive view on Turning Point Brands based on solid operational execution and promising growth in tobacco-free nicotine pouches. The investment thesis is supported by management's positive guidance and the introduction of new metrics that demonstrate progress in the high-growth nicotine pouch segment. The tobacco-free nicotine pouches represent a compelling growth opportunity as this segment gains market share in the evolving tobacco alternatives landscape. Strong core business execution provides a stable foundation while the company capitalizes on secular trends toward reduced-risk products. The manager's position reduction appears to be profit-taking based on valuation discipline rather than fundamental concerns. The company's branded consumer products portfolio and exposure to growing alternative tobacco segments position it well for continued growth. Management's transparency through new metrics demonstrates confidence in the business trajectory.

Pitch Summary:
Mirion Technologies, Inc., a global leader in ionizing radiation measurement and detection, provides critical technologies for the nuclear power and medical sectors. Mirion operates in industries with strong secular trends, and a significant portion of the company's revenues are recurring or replacement, which provides valuable transparency and predictability. During the quarter, strong earnings and secular tailwinds tied to rising demand for nuclear power, including AI-related data center energy needs, propelled the stock higher. We trimmed our position based on our valuation discipline as the share price increased during the period.

BSD Analysis:
The manager presents a bullish thesis on Mirion Technologies based on its leadership position in radiation detection and measurement technologies. The investment case centers on strong secular trends in nuclear power and medical sectors, with a significant portion of revenues being recurring or replacement-based, providing revenue visibility. The company benefited from rising demand for nuclear power driven by AI-related data center energy needs, which served as a key catalyst during the quarter. Strong earnings performance validated the investment thesis and drove share price appreciation. The manager's decision to trim the position reflects disciplined valuation management rather than a change in fundamental outlook. The recurring revenue model and exposure to nuclear power growth trends position Mirion favorably for continued performance. The AI-driven energy demand represents a compelling long-term tailwind for the nuclear power sector.

Pitch Summary:
MSC Industrial Direct: The company is a leading North American distributor of metalworking and maintenance, repair, and operations products and services. A slowdown in MSC's end markets apparently caused declining sales and weak quarterly results, which hurt the stock price. We believe these issues are temporary and see attractive upside potential to our estimate of long-term intrinsic value.

BSD Analysis:
Invesco's investment in MSC Industrial Direct represents a classic value play on a cyclical downturn in industrial end markets. The fund managers view the company's leading position in North American MRO distribution as a sustainable competitive advantage that will drive long-term value creation. Recent weakness in MSC's end markets led to declining sales and disappointing quarterly results, creating what the managers believe is a temporary headwind that has pressured the stock price below intrinsic value. The contrarian investment approach reflects confidence that current operational challenges are cyclical rather than structural in nature. MSC's established distribution network, customer relationships, and market position in essential MRO products should provide resilience during the eventual recovery. The managers appear to be capitalizing on short-term market pessimism to establish a position in a quality industrial distributor at an attractive valuation. This investment aligns with the fund's focus on economically sensitive stocks trading below estimated intrinsic value.

Pitch Summary:
Onto Innovation: The company is a semiconductor capital equipment manufacturer that provides process control solutions for microelectronics manufacturing, including defect inspection, metrology systems and software to enhance yield and reduce costs. The company has benefited from the artificial intelligence (AI) boom, but weakness during the quarter provided an attractive entry point for the fund.

BSD Analysis:
Invesco identified Onto Innovation as a compelling value opportunity following quarterly weakness that created an attractive entry point below intrinsic value. The company operates in the critical semiconductor capital equipment space, providing essential process control solutions including defect inspection and metrology systems that help manufacturers improve yields and reduce costs. While Onto Innovation has been a beneficiary of the AI-driven semiconductor boom, recent near-term softness provided the fund managers with an opportunity to establish a position at what they viewed as a discount. The company's focus on yield enhancement and cost reduction solutions positions it well within the semiconductor manufacturing ecosystem. Given the cyclical nature of semiconductor equipment demand, the managers appear to be taking a contrarian approach by investing during a period of temporary weakness. The AI megatrend should continue to drive long-term demand for advanced semiconductor manufacturing capabilities.

Pitch Summary:
ICON: The company is the largest pure-play (a company that focuses on a particular product or service in order to obtain a large market share in that space) contract research organization (CRO) and a leading global player in the industry's oligopoly. The company leverages therapeutic expertise and economies of scale to provide value to pharmaceutical and biotech clients. Increases in the complexity, duration and cost of drug development have increased the importance of scale for contract research companies and have also accelerated outsourcing in recent years. We believe ICON is well positioned to benefit from these trends. Recent lackluster financial results gave us the opportunity to buy the stock at what we saw as a significant discount to our estimate of intrinsic value.

BSD Analysis:
Invesco's managers view ICON as an attractive value opportunity following recent underperformance that created a compelling entry point. The fund emphasizes ICON's dominant position as the largest pure-play CRO operating within an oligopolistic industry structure, which provides significant competitive advantages. The investment thesis centers on secular tailwinds driving increased outsourcing in drug development, as pharmaceutical companies seek to manage rising complexity, duration, and costs of clinical trials. ICON's scale advantages and therapeutic expertise position it well to capture market share as these outsourcing trends accelerate. The managers believe recent weak financial results were temporary and created an opportunity to purchase shares at a meaningful discount to intrinsic value. This contrarian approach aligns with the fund's value-oriented investment philosophy of capitalizing on short-term market volatility. The CRO industry's oligopolistic structure and high barriers to entry support the long-term investment case.

Pitch Summary:
API completed its sale of its assets to GoldenTree at the end of November. Proceeds were directed to an initial distribution of 52p a share payable on the 24th December, by issue and redemption of bonus shares. A further distribution of 3p a share is payable as dividend on the 10th January. We retain our rump API shares which trade for a -37% discount to NAV composed mostly of cash and the Company's interest in a natural capital asset at Far Ralia.

BSD Analysis:
Marlton's position in abrdn Property Income Trust demonstrates successful execution of a liquidation strategy with ongoing value potential. The completed asset sale to GoldenTree generated immediate cash returns through the 52p initial distribution and 3p follow-on dividend, providing concrete value realization. The manager retains rump shares trading at a 37% discount to NAV, which consists primarily of cash and a natural capital asset interest. This creates a compelling risk-adjusted opportunity given the high cash component and discount to liquidation value. The natural capital asset at Far Ralia provides potential upside optionality beyond the cash value. The substantial discount on what is essentially a cash-heavy liquidating entity suggests limited downside with meaningful upside potential. This investment showcases Marlton's ability to capture value through multiple phases of corporate actions while maintaining exposure to residual value opportunities.

Pitch Summary:
On the 20th December, shareholders voted in favour of both EGM proposals, and JARA formally entered managed wind-down. Announcing November-end NAV of ~£0.96, versus our cost basis established in early-November, we created a position in the liquidation at an effective -25% discount to NAV.

BSD Analysis:
Marlton's investment in JARA represents a classic liquidation arbitrage opportunity with attractive risk-adjusted returns. The manager established a position in early November at a 25% discount to the November-end NAV of £0.96, creating immediate value capture potential. The December shareholder vote approving the managed wind-down provides certainty around the liquidation process and timeline. This investment aligns perfectly with Marlton's strategy of investing in asset-covered situations with hard catalysts. The 25% discount to NAV in a liquidation scenario offers compelling upside with limited downside risk, as liquidation proceeds should approximate NAV. The quick execution from position establishment to shareholder approval demonstrates efficient opportunity identification and capital deployment. This type of special situation exemplifies the fund's ability to generate returns through discount capture in corporate events.

Pitch Summary:
On the 18th December, JGC announced the Board is proposing a scheme of reconstitution and voluntary liquidation, under which shareholders would have the option to either: (1) roll-over their investment in JGC into units into a correspond Jupiter unit trust, or (2) exit in cash at a modest discount to NAV. The announcement concludes Marlton's successful and constructive engagement with JGC. Following a period when shares traded at a discount of up to 33% to liquid NAV in the second quarter, Chair Michael Naylor initiated a strategic review in July 2024. We acquired shares at a high-teens discount to NAV and engaged with the Board proposing an exchange offer, allowing eligible shareholders to exchange their JGC shares for units in the Jupiter Ecology Fund, or to exit in cash close to NAV. We are pleased to see the proposed scheme closely align with our suggestion. We believe the Board's proposal is in the best interest of shareholders and expect broad support across the register. We would like to express our particular gratitude to Mr. Jaz Bains, Senior Independent Director, with whom we engaged and found to be a conscientious and capable independent director.

BSD Analysis:
Marlton's investment in Jupiter Green Investment Trust represents a successful activist engagement that achieved the desired outcome. The manager identified an opportunity when shares traded at up to 33% discount to NAV and acquired a position at a high-teens discount. Through constructive engagement with the board, Marlton proposed an exchange offer solution that was ultimately adopted by management. The December announcement of voluntary liquidation with shareholder optionality validates the investment thesis and activist approach. Shareholders can either roll into the Jupiter Ecology Fund or exit at near-NAV pricing, effectively eliminating the discount that created the opportunity. This outcome demonstrates Marlton's ability to identify discount situations and catalyze value realization through engagement. The successful resolution within months of the strategic review initiation shows efficient capital deployment. This investment exemplifies the fund's strategy of acquiring discounted closed-end funds with potential for corporate action catalysts.

Pitch Summary:
On the 9th December, Vivendi shareholders voted in favour of the a four-way split, which resulted in the spin-off of Canal+ (CAN.LN), Havas (HAVAS.AMS) and Louis Hachette Group (ALHG.PA) from Vivendi. A "stub" RemainCo continued trading under the existing VIV.PA ticker. On the 16th December, the three new entities began trading. We fundamentally misappraised both the collective value the market was willing to ascribe to the parts on break-up, and the market's reaction to the event, as reflected in Bolloré's discount. The most significant deviation from our expectations was in the valuation of Canal+. After adjusting for stakes in MultiChoice (MCG.JSE), Viaplay (VPLAY-B.STO), and the Viu JV, Canal+ is now trading at approximately 2x EV/EBITDA. In contrast, the Vivendi RemainCo is trading at a discount of over 50% to its liquid portfolio. Following the spin-off, the sum-of-the-parts (SOTP) discount at the Bolloré level widened substantially, contrary to our expectation of either a discount-neutral or narrowing outcome. We have reduced our position in Bolloré by approximately 50%, realizing a 350bps gross loss relative to our cost basis. While we believe significant value remains to be unlocked, we view the catalyst path through the first half of 2025 as minimal. Key catalysts include the consolidation of the ex-Rivaud entities, with increased offers in both cash and UMG share exchange terms. Additionally, we anticipate a modest tailwind from buybacks at both the Bolloré and Compagnie de l'Odet (ODET.PA) levels.

BSD Analysis:
Marlton's position in Bolloré represents a significant misjudgment of market dynamics around the Vivendi spin-off transaction. The manager expected the four-way split to either maintain or narrow the sum-of-the-parts discount, but instead witnessed substantial discount widening. Canal+ trades at an extremely low 2x EV/EBITDA multiple while Vivendi RemainCo trades at over 50% discount to its liquid portfolio, creating an unexpected valuation disconnect. The 350 basis point loss and 50% position reduction demonstrate the manager's recognition of the failed thesis. Despite believing value remains, Marlton acknowledges minimal near-term catalysts through H1 2025. The remaining catalysts include ex-Rivaud entity consolidation and potential buybacks, but these appear insufficient to drive meaningful value realization. This position highlights the risks inherent in complex conglomerate discount plays where market behavior can deviate significantly from rational expectations.

Pitch Summary:
Early in the month, PRS announced that the newly constituted Board had made available a data room, and is in active discussions with multiple parties regarding a potential sale of the company. We expect updates both on the strategic review and the formal sales process in the first quarter of 2025. In our view that there remains substantial upside from here in the event of a sale of the company. Pending portfolio completion and stabilization, we believe PRS commands a look-through NAV of ~£1.37 to ~£1.41. Traded prices at December-end correspond to a discount of -21.5% to -23.7%.

BSD Analysis:
Marlton maintains a bullish stance on PRS REIT based on a classic asset-backed value play with a clear catalyst. The company is actively pursuing a strategic sale process with multiple bidders, providing a concrete catalyst for value realization. The manager's analysis indicates the REIT trades at a significant discount to net asset value, with shares priced 21.5% to 23.7% below the estimated look-through NAV of £1.37 to £1.41. This represents a compelling risk-adjusted opportunity given the active sale process and data room availability. The investment thesis centers on the expectation that a sale will unlock the discount to NAV, providing substantial upside. The first quarter of 2025 timeline for updates creates a near-term catalyst window. This position exemplifies Marlton's strategy of investing in asset-covered situations with hard catalysts to unlock value.